Renovaro Inc. has announced the filing of a new patent application titled "Methods, Systems, and Frameworks for Unbiased Data in Drug Discovery Predictions." This development strengthens the company's intellectual property portfolio, focusing on real-time, reproducible analytics across distributed computing environments. The patent application supports Renovaro's scalable drug discovery and diagnostics business by protecting its machine learning infrastructure for multi-modal biomedical data integration and predictive analytics.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。